Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...
Eliem Therapeutics’ Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Velocity Global’s $400 Million Series B Financing Round
Cooley advised Velocity Global on the deal. Velocity Global, a leading provider of global talent solutions, announced its $400 million Series B financing round. With the fundraise,...